Cite
FRI-263 Severity of hepatic steatosis measured with controlled attenuation parameter as a determinant of carotid atherosclerosis in the Raine Study.
MLA
Ayonrinde, Oyekoya, et al. “FRI-263 Severity of Hepatic Steatosis Measured with Controlled Attenuation Parameter as a Determinant of Carotid Atherosclerosis in the Raine Study.” Journal of Hepatology, vol. 80, June 2024, pp. S487–88. EBSCOhost, https://doi.org/10.1016/S0168-8278(24)01490-9.
APA
Ayonrinde, O., Adams, L., Zelesco, M., Welman, C., Mori, T., Melton, P., Mould, A., Beilin, L., Fiori, J., Dwivedi, G., Sanfilippo, F., & Olynyk, J. (2024). FRI-263 Severity of hepatic steatosis measured with controlled attenuation parameter as a determinant of carotid atherosclerosis in the Raine Study. Journal of Hepatology, 80, S487–S488. https://doi.org/10.1016/S0168-8278(24)01490-9
Chicago
Ayonrinde, Oyekoya, Leon Adams, Marilyn Zelesco, Christopher Welman, Trevor Mori, Phillip Melton, Andrea Mould, et al. 2024. “FRI-263 Severity of Hepatic Steatosis Measured with Controlled Attenuation Parameter as a Determinant of Carotid Atherosclerosis in the Raine Study.” Journal of Hepatology 80 (June): S487–88. doi:10.1016/S0168-8278(24)01490-9.